Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)

18.25 +0.56 (+3.19%)
Streaming Delayed Price Updated: 9:54 AM EST, Nov 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sarepta Therapeutics, Inc. - Common Stock

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
News headline image
NVDA Stock Price Prediction: Morgan Stanley Issues $304 Price Target for Nvidia Shares ↗
Nvidia (NVDA) stock is on the move Friday as investors react to a new price target from Morgan Stanley analyst Joseph Moore. 
Via InvestorPlace
News headline image
Why Is Sarepta Therapeutics (SRPT) Stock Down 20% Today? ↗
Sarepta Therapeutics (SRPT) stock is sliding lower on Friday after the company announced an advisory committee meeting with the FDA. 
Via InvestorPlace
News headline image
Sarepta Crashes On An Unexpected Roadblock For Its Gene Therapy ↗
The decision is an about-face from what Sarepta said roughly two weeks ago. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning! 
Via InvestorPlace
News headline image
The Latest Analyst Ratings for Sarepta Therapeutics ↗
 
Via Benzinga
News headline image
Why Sarepta Therapeutics Shares Are Trading Lower By Around 19%; Here Are 20 Stocks Moving Premarket ↗
Gainers Enzo Biochem, Inc. (NYSE: ENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell its clinical laboratory to Labcorp. 
Via Benzinga
News headline image
Nasdaq, S&P Futures Dip, Signaling Pause In Rally As Focus Shifts To Next Week's Fed Decision: Analyst Says Brace For More Volatility Near Term ↗
The mood on Wall Street continues to be jittery, with the major index futures trading marginally to modestly lower. The weak sentiment reflected apprehensions concerning how the banking crisis will... 
Via Benzinga
News headline image
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SRPT
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Sarepta Therapeutics Announces Advisory Committee Meeting will be Held for SRP-9001
From Sarepta Therapeutics, Inc.
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
News headline image
Meta Platforms To Rally 27%? Here Are 10 Other Analyst Forecasts For Thursday ↗
Wells Fargo cut the price target for SVB Financial Group (NASDAQ: SIVB) from $350 to $300. Wells Fargo analyst Steven Shaw maintained an Overweight rating. SVB Financial shares fell 29.1% to $190.02 in... 
Via Benzinga
News headline image
2 Biotech Stocks You Can Buy and Hold for the Next Decade ↗
Regeneron and Sarepta Therapeutics have been on fire so far this year. 
Via The Motley Fool
News headline image
Stock Market Rally Rebounds Despite Rising Yields; Salesforce, Tesla In Focus: Weekly Review ↗
Many leaders flashed buy signals as the indexes rebounded from support. 
Via Investor's Business Daily
News headline image
Why Sarepta Therapeutics' Shares Rose 23.4% This Week ↗
The company's latest Duchenne muscular dystrophy gene therapy may have an accelerated approval. 
Via The Motley Fool
News headline image
3 Best Growth Stocks to Buy In March ↗
These three red-hot growth stocks have more room to run. 
Via The Motley Fool
News headline image
Why Sarepta Therapeutics Stock Is Booming Today ↗
Sarepta Therapeutics (NASDAQ: SRPT) shares are trading higher this Wednesday after the company reported better-than-expected fourth-quarter results. 
Via Benzinga
News headline image
Why This Sarepta Therapeutics Is Turning Bullish ↗
Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) jumped in early trading on Wednesday, after the company reported an earnings beat for its fourth quarter. 
Via Benzinga
News headline image
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
News headline image
Sarepta Rockets And Breaks Out As FDA Smooths The Path For Its Gene Therapy ↗
The FDA will not hold an advisory committee meeting for the company's gene therapy. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 ↗
 
Via Benzinga
News headline image
Why Is Sarepta Therapeutics (SRPT) Stock Up 21% Today? ↗
Sarepta Therapeutics (SRPT) stock is heading higher on Wednesday following the release of its latest earnings report and an upgrade. 
Via InvestorPlace
News headline image
Investors Just Hit the Jackpot on These 2 Nasdaq Biotech Stocks ↗
Markets are trying to rise, and these companies are helping out. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Sarepta Therapeutics To Rally Over 53%? Here Are 10 Other Analyst Forecasts For Wednesday ↗
Keybanc raised the price target for Ambarella, Inc. (NASDAQ: AMBA) from $95 to $105. Keybanc analyst John Vinh maintained an Overweight rating. Ambarella shares fell 7.1% to $87.61 in pre-market... 
Via Benzinga
News headline image
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket ↗
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday! 
Via InvestorPlace
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.